Proto-Oncogene Proteins c-akt, antagonists & inhibitors
- Name
- Proto-Oncogene Proteins c-akt, antagonists & inhibitors
- Accession Number
- DBCAT003064
- Description
Not Available
- Drugs
Drug Drug Description Ipatasertib Ipatasertib has been used in trials studying the treatment of Cancer, Neoplasms, Solid Cancers, Breast Cancer, and Gastric Cancer, among others. Capivasertib A serine/threonine kinase inhibitor used to treat hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer - Drugs & Drug Targets